Jung Minsuk and An Moonhwan Named Recipients of This Year's "Proud Hanmi Award"

Contributions to the Development of "Amoprel" and Advancement of Production Processes

The "Proud Hanmi Award" ceremony, which is presented to Hanmi Group employees, was held on the morning of October 2 at the Hanmi Group headquarters in Songpa-gu, Seoul.

On the 2nd, at the Hanmi Group headquarters in Songpa-gu, Seoul, An Moonhwan, Group Leader (left), and Jung Minsuk, Group Leader, who were award recipients, are taking a commemorative photo at the 6th Proud Hanmi Award ceremony. Hanmi Pharmaceutical

Now in its sixth year, this award was established by Chairwoman Song Youngsook, who has led Hanmi Group since the passing of the founder, the late Im Sungki. The purpose is to discover and encourage frontline employees who quietly achieve results behind the scenes. The award is given to "working-level employees" who have demonstrated Hanmi’s core values of "creativity, challenge, and innovation" in their respective fields over the past year.

About 30 people attended the ceremony, including Hanmi Group Vice Chairman Lim Juhyun, Hanmi Science CEO Kim Jaekyo, Hanmi Pharmaceutical CEO Park Jaehyun, Hanmi Science Vice President (CFO) Shim Byunghwa, other Hanmi Group executives and employees, and the families of the award recipients.

This year, two recipients were selected for the Proud Hanmi Award: Jung Minsuk, Group Leader of the New Product Clinical Team at the New Product Development Division of Hanmi Pharmaceutical, and An Moonhwan, Group Leader of the Quality Team at the Paltan Manufacturing Division of Hanmi Pharmaceutical. Each recipient was presented with a 100g gold bar engraved with the Hanmi CI and a plaque.

Jung Minsuk was highly praised for successfully leading the clinical trials and achieving outstanding results for "Amoprel," the world’s first low-dose triple antihypertensive agent, which is expected to become the "second Rosuzet." She was recognized for conducting the clinical trials in a systematic and thorough manner.

An Moonhwan was recognized for his significant contributions to enhancing and streamlining the overall process, including establishing and operating a quality data prediction system, in order to support Hanmi’s core competitiveness in "high-quality pharmaceutical production."

Kim Jaekyo, who presented the awards, stated, "Hanmi Group members possess the ‘strength’ to establish strategies and devote themselves to their work in order to practice the legacy of creativity, challenge, and innovation left by the late Chairman Im Sungki. We will continue to make every effort to protect these valuable assets of Hanmi and to further develop Hanmi’s corporate climate and culture."

Park Jaehyun, who also attended the ceremony, commented, "The two Group Leaders who received awards today have best embodied the Hanmi spirit in the fields of pharmaceutical development and production. I hope this ceremony will serve as a reminder of the values of creativity, challenge, and innovation left by the late Chairman Im, and become an event that continues alongside Hanmi’s history."

Meanwhile, following the ceremony, Hanmi Group also presented pure gold and appreciation plaques to 165 employees who have worked for 10, 20, or 30 years, in recognition of their long service in accordance with the company’s long-term service award criteria.